Skip to main content
SpringerLink
Log in

Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors

  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Repetitive thoughts and behavior are considered integral and core components of autistic disorder. Results from recent studies suggest that the types of repetitive thoughts and behavior of adults with autism and those with obsessive-compulsive disorder (OCD) may be different. Serotonin reuptake inhibitors (SRIs), the primary drug treatment for patients with OCD, may reduce the repetitive phenomena of some autistic patients. Two controlled studies of the nonselective SRI clomipramine have shown the drug to be more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. One controlled study of the selective SRI fluvoxamine found it to be significantly better than placebo for reducing repetitive phenomena and aggression in adults with autistic disorder. Additional research is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

    Google Scholar 

  • Baron-Cohen, S. (1989). Do autistic children have obsessions and compulsions? British Journal of Clinical Psychology, 28, 193–200.

    PubMed  Google Scholar 

  • Baron-Cohen, S., & Wheelwright, S. (1999). “Obsession” in children with autism or Asperger's syndrome. British Journal of Psychiatry, 175, 484–490.

    Google Scholar 

  • Branford, D., Bhaumik, S., & Naik, B. (1998). Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability. Journal of Intellectual Disability Research, 42, 301–306.

    PubMed  Google Scholar 

  • Brasic, J. R., Barnett, J. Y., Kaplan, D., Sheitman, B. B., Aisemberg, P., Lafargue, R. T., Kowalik, S., Clark, A., Tsaltas, M. O., & Young, J.G. (1994). Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology, 44, 1309–1312.

    PubMed  Google Scholar 

  • Brasic, J. R., Barnett, J. Y., Sheitman, B. B., Lafargue, R. T., Kowalik, S., Kaplan, D., Tsaltas, M. O., Ahmad, R., Nadrich, R. H., & Mendonca, M. F. (1998). Behavioral effects of clomipramine on prepubertal boys with autistic disorder and severe mental retardation. CNS Spectrums, 3, 39–46.

    Google Scholar 

  • Brodkin, E. S., McDougle, C. J., Naylor, S. T., Cohen, D. J., & Price, L. H. (1997). Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Child and Adolescent Psychopharmacology, 7, 109–121.

    PubMed  Google Scholar 

  • Buck, O. D. (1995). Sertraline for reduction of violent behavior. American Journal of Psychiatry, 152, 953.

    Google Scholar 

  • Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.

    PubMed  Google Scholar 

  • Cook, E. H., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., & Leventhal, B. L. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2, 247–250.

    PubMed  Google Scholar 

  • Cook, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.

    PubMed  Google Scholar 

  • Damore, J., Stine, J., & Brody, L. (1998). Medication-induced hypomania in Asperger's disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 248–249.

    PubMed  Google Scholar 

  • Davanzo, P. A., Belin, T. R., Widawski, M. H., & King, B. H. (1998). Paroxetine treatment of aggression and self-injury in persons with mental retardation. American Journal on Mental Retardation, 102, 427–437.

    PubMed  Google Scholar 

  • DeLong, G. R., Teague, L. A., & Kamran, M. M. (1998). Effects of fluoxetine treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40, 551–562.

    PubMed  Google Scholar 

  • Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism and Developmental Disorders, 28, 303–307.

    PubMed  Google Scholar 

  • Foa, E. B. (1979). Failures in treating obsessive-compulsives. Behavioral Research and Therapy, 7, 169–176.

    Google Scholar 

  • Garber, H. J., McGonigle, J. J., Slomka, G. T., & Monteverde, E. (1992). Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1157–1160.

    PubMed  Google Scholar 

  • Ghaziuddin, M., Tsai, L., & Ghaziuddin, N. (1991). Fluoxetine in autism with depression. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 508–509.

    Google Scholar 

  • Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989b). The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity. Archives of General Psychiatry, 46, 1012–1016.

    PubMed  Google Scholar 

  • Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989a). The Yale-Brown Obsessive Compulsive Scale (YBOCS): Part I. Development, use, and reliability. Archives of General Psychiatry 46, 1006–1011.

    PubMed  Google Scholar 

  • Gordon, C. T., Rapoport, J. L., Hamburger, S. D., State, R. C., & Mannheim, G. B. (1992). Differential response of seven subjects with autistic disorder to clomipramine and desipramine. American Journal of Psychiatry, 149, 363–366.

    Google Scholar 

  • Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.

    PubMed  Google Scholar 

  • Guy, W. (1976). ECDEU Assessment manual for psychopharmacology, U.S. Dept of Health, Education, and Welfare, Publication 76–338, Washington DC.

    Google Scholar 

  • Hamdan-Allen, G. (1991). Brief report: Trichotillomania in an autistic male. Journal of Autism and Developmental Disorder, 21, 79–82.

    Google Scholar 

  • Harvey, R. J., & Cooray, S. E. (1995). The effective treatment of severe repetitive behaviour with fluvoxamine in a 20 year old autistic female. International Clinical Psychopharmacology, 10, 210–203.

    Google Scholar 

  • Hellings, J. A, Kelley, L. A., Gabrielli, W. F., Kilgore, E., & Shah, P. (1996). Sertraline response in adults with mental retardation and autistic disorder. Journal of Clinical Psychiatry, 53, 333–336.

    Google Scholar 

  • Hoder, E. L., & Cohen, D. J. (1983). Repetitive behavior patterns of childhood. In M. Levine & W. Carey (Eds.), Developmental-behavioral Pediatrics. Philadelphia: Saunders, pp. 607–622.

    Google Scholar 

  • Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2, 217–250.

    Google Scholar 

  • Koshes, R. J. (1997). Use of fluoxetine for obsessive-compulsive behavior in adults with autism. American Journal of Psychiatry, 154, 578.

    Google Scholar 

  • Leonard, H. L., Swedo, S. E., Rapoport, J. L., Coffey, M., & Cheslow, D. (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. Archives of General Psychiatry, 46, 1088–1092.

    PubMed  Google Scholar 

  • Lindley, P., Marks, I., Philpott, R., & Snowden, J. (1977). Treatment of obsessive-compulsive neurosis with history of childhood autism. British Journal of Psychiatry, 130, 592–597.

    Google Scholar 

  • McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., Shapiro, T., & Cohen, D. J. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776.

    PubMed  Google Scholar 

  • McDougle, C. J. (1997). Psychopharmacology. In Cohen, D. J., & Volkmar, F. R. (Eds.), Handbook of autism and developmental disorders (2nd ed., pp. 707–729). New York: Wiley.

    Google Scholar 

  • McDougle, C. J. (1998). Repetitive thoughts and behavior in pervasive developmental disorders: Phenomenology and pharmacotherapy. In E. Schopler, G. B. Mesibov, & L. J. Kunce (Eds), Asperger syndrome or high functioning autism? Current issues in autism series (pp. 293–316). New York: Plenum Press.

    Google Scholar 

  • McDougle, C. J. (1999). The neurobiology and treatment of obsessive-compulsive disorder. In D. S. Charney, E. J. Nestler, & B. S. Bunney (Eds.), Neurobiology of mental illness (pp. 518–533). New York: Oxford University Press.

    Google Scholar 

  • McDougle, C. J., Brodkin, E. S., Naylor, S. T., Carlson, D. C., Cohen, D. J., & Price, L. H. (1998). Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Clinical Psychopharmacology, 18, 62–66.

    PubMed  Google Scholar 

  • McDougle, C. J., Kresch, L. E., Goodman, W. K., Naylor, S. T., Volkmar, F. R., Cohen, D. J., & Price, L. H. (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 772–777.

    PubMed  Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.

    PubMed  Google Scholar 

  • McDougle, C. J., Price, L. H., & Goodman, W. K. (1990). Fluvoxamine treatment of coincident autistic disorder and obsessive compulsive disorder: A case report. Journal of Autism and Developmental Disorders, 20, 537–543.

    PubMed  Google Scholar 

  • McDougle, C. J., Price, L. H., Volkmar, F. R., Goodman, W. K., Ward-O'Brien, D., Nielsen, J., Bregman, J., & Cohen, D. J. (1992). Clomipramine in autism: Preliminary evidence of efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 746–750.

    PubMed  Google Scholar 

  • Mehlinger, R., Scheftner, W. A., & Poznanski, E. (1990). Fluoxetine and autism. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 985.

    Google Scholar 

  • Ozbayrak, K. R. (1997). Sertraline in PDD. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 7–8.

    PubMed  Google Scholar 

  • Posey, D. J., Litwiller, M., Kohburn, A., & McDougle, C. J. (1999). Paroxetine in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 111–112.

    PubMed  Google Scholar 

  • Potenza, M. N., & McDougle, C. J. (1997). The role of serotonin in autism-spectrum disorders. CNS Spectrums, 2, 25–42.

    Google Scholar 

  • Prior, M., & Macmillan, M. B. (1973). Maintenance of sameness in children with Kanner's syndrome. Journal of Autism and Childhood Schizophrenia, 3, 154–167.

    PubMed  Google Scholar 

  • Rapoport, J. L., Swedo, S. E., & Leonard, H. L. (1992). Childhood obsessive-compulsive disorder. Journal of Clinical Psychiatry, 53, 11–16.

    PubMed  Google Scholar 

  • Rumsey, J. M., Rapoport, J. L., & Sceery, W. R. (1985). Autistic children as adults: Psychiatric, social and behavioral outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 465–473.

    Google Scholar 

  • Sanchez, L. E., Campbell, M., Small, A. M., Cueva, J. E., Armenteros, J. L., & Adams, P. B. (1996). A pilot study of clomipramine in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 537–544.

    PubMed  Google Scholar 

  • Sloman, L., & Nicolson, R. (1999). Medication in pervasive developmental disorder. Child and Adolescent Psychopharmacology News, 4, 4–9.

    Google Scholar 

  • Snead, R. W., Boon, F., & Presberg, J. (1994). Paroxetine for self-injurious behavior. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 909–910.

    PubMed  Google Scholar 

  • Steingard, R. J., Zimnitzky, B., DeMaso, D. R., Bauman, M. L., & Bucci, J. P. (1997). Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 7, 9–15.

    PubMed  Google Scholar 

  • Todd, R. D. (1991). Fluoxetine in autism. American Journal of Psychiatry, 148, 1089.

    Google Scholar 

  • Turner, M. (1999). Annotation: Repetitive behaviour in autism: A review of psychological research. Journal of Child Psychology and Psychiatry, 40, 839–849.

    PubMed  Google Scholar 

  • Volkmar, F. R., Hoder, E. L., & Cohen, D. J. (1985). Compliance, “negativism,” and the effects of treatment structure in autism: A naturalistic, behavioral study. Journal of Child Psychology and Psychiatry, 26, 865–877.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Section of Child and Adolescent Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana

    Christopher J. McDougle & David J. Posey

Authors
  1. Christopher J. McDougle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura E. Kresch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Posey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDougle, C.J., Kresch, L.E. & Posey, D.J. Repetitive Thoughts and Behavior in Pervasive Developmental Disorders: Treatment with Serotonin Reuptake Inhibitors. J Autism Dev Disord 30, 427–435 (2000). https://doi.org/10.1023/A:1005551523657

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005551523657

Search

Navigation